CCL19 and cancer: The F_6 CCL19+ fibroblasts have been shown to interact with T-cells via CXCL12/CXCR4 and F_8 MMP1+ myofibroblasts (myoF) have recently been linked to an immunosuppressive neighborhood in cancer (13, 29, 30).